XOMA Royalty (XOMA) Net Cash Flow (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Net Cash Flow came in at $5.0 million in Q1 2026, up 144.19% year-on-year from $2.1 million in Q1 2025, and up 59.42% quarter-over-quarter from $3.2 million in Q4 2025.

XOMA Royalty (XOMA) Net Cash Flow (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Net Cash Flow across 17 years of filings, most recently posting $5.0 million for Q1 2026.

  • Net Cash Flow for Q1 2026 came in at $5.0 million, up 144.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.7 million (up 192.28% YoY), and the FY2025 annual result was $27.3 million, up 151.37% from the prior year.
  • Net Cash Flow came in at $5.0 million for Q1 2026 at XOMA Royalty, up from $3.2 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $126.1 million in Q4 2023 to a low of -$40.4 million in Q4 2024.
  • The 5-year median for Net Cash Flow is -$5.5 million (2022), against an average of $2.6 million.
  • Peak annual rise in Net Cash Flow reached 1777.45% in 2025, while the deepest fall reached 320.0% in 2025.
  • XOMA Royalty's Net Cash Flow stood at -$20.5 million in 2022, then soared by 716.25% to $126.1 million in 2023, then plunged by 132.04% to -$40.4 million in 2024, then jumped by 107.81% to $3.2 million in 2025, then soared by 59.42% to $5.0 million in 2026.
  • The last three Net Cash Flow figures came in at $5.0 million (Q1 2026), $3.2 million (Q4 2025), and $52.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 2.44 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 625.70 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -2.44 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 457.40 Mn
9 Abivax 95.45 Bn 95.45 Bn - 664,983.53
10 XOMA Royalty 5.52 Mn -60.56 Mn - 5.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.03 Mn
Mar 31, 2026 5.03 Mn
Dec 31, 2025 3.16 Mn
Dec 31, 2025 3.16 Mn
Sep 30, 2025 52.07 Mn
Sep 30, 2025 52.07 Mn
Jun 30, 2025 -16.54 Mn
Jun 30, 2025 -16.54 Mn
Mar 31, 2025 -11.39 Mn
Mar 31, 2025 -11.39 Mn
Dec 31, 2024 -40.40 Mn
Dec 31, 2024 -40.40 Mn
Sep 30, 2024 -3.10 Mn
Sep 30, 2024 -3.10 Mn
Jun 30, 2024 7.52 Mn
Jun 30, 2024 7.52 Mn
Mar 31, 2024 -17.15 Mn
Mar 31, 2024 -17.15 Mn
Dec 31, 2023 126.08 Mn
Dec 31, 2023 126.08 Mn